BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2572133)

  • 1. Isofloxythepine in an open study.
    Papezová H; David I; Alda M; Soucek R
    Act Nerv Super (Praha); 1989 Jun; 31(2):121-2. PubMed ID: 2572133
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effectiveness of isofloxythepin--an open study].
    Zapletálek M; Tůma I; Kudrnová K
    Cesk Psychiatr; 1985 Aug; 81(4):242-6. PubMed ID: 2864141
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
    Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
    Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
    [No Abstract]   [Full Text] [Related]  

  • 6. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
    Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
    Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.
    Pai MS; Yang SN; Shiah IS
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):538. PubMed ID: 23066778
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual evoked potentials during the treatment with isofloxythepine.
    Libiger J; Kuba M; Zapletálek M; Dostál J
    Act Nerv Super (Praha); 1989 Apr; 31(1):34-5. PubMed ID: 2571219
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
    Hashimoto K; Sudo T; Hirano M; Motomura H; Tagawa K; Nashiro S; Uemura K; Yoshimoto S
    Schizophr Res; 2006 Oct; 87(1-3):332-3. PubMed ID: 16797164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Body weight increase: a side effect of zotepin (Nipolept)?].
    Wetterling T; Müssigbrodt H
    Nervenarzt; 1996 Mar; 67(3):256-61. PubMed ID: 8901286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octoclothepin in psychoses. A controlled clinical trial.
    Vinar O; Ledererová E; Taussigová D
    Act Nerv Super (Praha); 1968 Oct; 10(3):336-9. PubMed ID: 4883241
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our first experimental and clinical experience with the neuroleptic isofloxythepin].
    Náhunek K; Svestka J; Cesková E; Rysánek R
    Cesk Psychiatr; 1984 Aug; 80(4):220-3. PubMed ID: 6149815
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of isofloxythepin].
    Pogády J; Martisová D; Varecka L
    Bratisl Lek Listy; 1988 Feb; 89(2):67-70. PubMed ID: 2896066
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with the neuroleptic zotepine--first results.
    Haug HJ
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):35-7. PubMed ID: 2883679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
    Hsu WC; Lin ST; Chen CC; Tsang HY; Huang MF
    J Clin Psychopharmacol; 2011 Oct; 31(5):667-9. PubMed ID: 21881455
    [No Abstract]   [Full Text] [Related]  

  • 17. Further clinical experience with oxyprothepin-decanoate.
    Kalvach Z; Hálková E; Bastecký J
    Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
    [No Abstract]   [Full Text] [Related]  

  • 18. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses].
    Cesková E; Svestka J; Rysánek R
    Cesk Psychiatr; 1993 Jan; 89(1):11-4. PubMed ID: 8099534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.